Possible FDA Approval For Vaccine Before Completion of Phase Three Trials

A Covid Vaccine Possible Early Release.

The U.S. Food and Drug Administration is willing to provide “emergency use authorization” for use of a vaccine before Phase Three clinical trials are complete, FDA Commissioner Stephen Hahn says. Hahn told The Financial Times that if a vaccine developer applies before concluding the crucial testing phase – involving tens of thousands of patients – the FDA might find authorization “appropriate.”ack of faith disturbing. 

Credits: USA Today